Abstract
Objective Abdominal aortic aneurysm (AAA) treatment is upon a diameter threshold by open (OAR) or endovascular aortic repair. So far, attempts for medical growth abrogation have failed. This study aims to elucidate the heterogeneity of AAA based on histomorphology in correlation to individual patient data and aneurysm metrics.
Patients and Methods Aneurysm samples from the left anterior wall from four university center biobanks underwent histologic analysis including angiogenesis, calcification, fibrosis, type and grade of inflammation in adventitia and media. Clinical information included age, comorbidities, etc., type of aneurysm (intact, symptomatic, ruptured, inflammatory) and growth. Aneurysm morphology included diameter and semi-automated geometric analysis using Endosize© (Therenva) and finite element methods (A4Clinics© Research Edition, Vacops GmbH).
Results 364 patients’ samples (85.4% male, median age 69 years) were evaluated and scored for acute (mixed/granulocytes) or chronic (mononuclear/plasma cells) inflammation, which was not associated with rupture (52x), symptomatic (37x; p = 0.51) or diameter (57 [52–69] mm; p = 0.87). The degree of fibrosis and the presence of angiogenesis were significantly higher (both p < 0.001) with increasing inflammation, which in turn significantly decreased with patient age (est = −0.015/year, p = 0.017). No significant differences in were seen for ruptured (vs. intact), acute (vs. elective), male (vs. female) or diabetic patients. Current smoking was associated with chronic inflammation (p = 0.007) and a higher degree of fibrosis (p = 0.03). Aneurysm geometric morphology (n=252) or annual growth rate (n=142) were not associated with histologic characteristics. Yet, local luminal thrombus formation was significantly higher with increasing inflammation (p = 0.04).
Conclusion Type and degree of inflammation are the most distinguishable histologic characteristics in the AAA wall between individual patients, yet not associated with diameter or rupture. Local luminal thrombus formation is associated with inflammatory features and suggests a vivid bio-physical compartment with intra-individual differences.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A one-year license of EndoSize (Therenva) and A4clinics Research Edition (Vascops) was funded by the German Heart Foundation (Deutsche Herzstiftung) with a grant given to A Busch (F/46/18).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was performed in accordance with the declaration of Helsinki and tissue sampling was approved by the local ethics committees of the individual centers (Ethikkommission Klinikum rechts der Isar: 2799/10; Ethikkommission Duesseldorf: 2019-578; Ethikkommission Wuerzburg: 188/11; Ethikkommission Wien: Ref 1729/2014). The HistAAA study was specifically approved for the leading center (Ethikkommission Klinikum rechts der Isar: 576/18S).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: A one-year license of EndoSize® (Therenva) and A4clinics Research Edition (Vascops) was funded by the German Heart Foundation (Deutsche Herzstiftung) with a grant given to A Busch (F/46/18).
Additional data has been added and mistakes were corrected.
Data Availability
All data produced in the present work are contained in the manuscript